These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38423454)
1. Skp2-Cyclin A Interaction Is Necessary for Mitotic Entry and Maintenance of Diploidy. Vasavan B; Das N; Kahnamouei P; Trombley C; Swan A J Mol Biol; 2024 Apr; 436(8):168505. PubMed ID: 38423454 [TBL] [Abstract][Full Text] [Related]
2. Skp2 regulates G2/M progression in a p53-dependent manner. Hu R; Aplin AE Mol Biol Cell; 2008 Nov; 19(11):4602-10. PubMed ID: 18716061 [TBL] [Abstract][Full Text] [Related]
3. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491 [TBL] [Abstract][Full Text] [Related]
4. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502 [TBL] [Abstract][Full Text] [Related]
5. Cks85A and Skp2 interact to maintain diploidy and promote growth in Drosophila. Ghorbani M; Vasavan B; Kraja E; Swan A Dev Biol; 2011 Oct; 358(1):213-23. PubMed ID: 21827746 [TBL] [Abstract][Full Text] [Related]
6. Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Kossatz U; Dietrich N; Zender L; Buer J; Manns MP; Malek NP Genes Dev; 2004 Nov; 18(21):2602-7. PubMed ID: 15520280 [TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373 [TBL] [Abstract][Full Text] [Related]
9. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1). Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332 [TBL] [Abstract][Full Text] [Related]
10. Bipartite binding of the N terminus of Skp2 to cyclin A. Kelso S; Orlicky S; Beenstock J; Ceccarelli DF; Kurinov I; Gish G; Sicheri F Structure; 2021 Sep; 29(9):975-988.e5. PubMed ID: 33989513 [TBL] [Abstract][Full Text] [Related]
11. Skp2 contains a novel cyclin A binding domain that directly protects cyclin A from inhibition by p27Kip1. Ji P; Goldin L; Ren H; Sun D; Guardavaccaro D; Pagano M; Zhu L J Biol Chem; 2006 Aug; 281(33):24058-69. PubMed ID: 16774918 [TBL] [Abstract][Full Text] [Related]
12. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate. Bornstein G; Ganoth D; Hershko A Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300 [TBL] [Abstract][Full Text] [Related]
13. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation. Appleman LJ; Chernova I; Li L; Boussiotis VA Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077 [TBL] [Abstract][Full Text] [Related]
14. Skp2-mediated degradation of p27 regulates progression into mitosis. Nakayama K; Nagahama H; Minamishima YA; Miyake S; Ishida N; Hatakeyama S; Kitagawa M; Iemura S; Natsume T; Nakayama KI Dev Cell; 2004 May; 6(5):661-72. PubMed ID: 15130491 [TBL] [Abstract][Full Text] [Related]
15. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression. Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624 [TBL] [Abstract][Full Text] [Related]
16. Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2. Yam CH; Ng RW; Siu WY; Lau AW; Poon RY Mol Cell Biol; 1999 Jan; 19(1):635-45. PubMed ID: 9858587 [TBL] [Abstract][Full Text] [Related]
17. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Ji P; Jiang H; Rekhtman K; Bloom J; Ichetovkin M; Pagano M; Zhu L Mol Cell; 2004 Oct; 16(1):47-58. PubMed ID: 15469821 [TBL] [Abstract][Full Text] [Related]
18. Disrupting Skp2-cyclin A interaction with a blocking peptide induces selective cancer cell killing. Ji P; Sun D; Wang H; Bauzon F; Zhu L Mol Cancer Ther; 2007 Feb; 6(2):684-91. PubMed ID: 17308064 [TBL] [Abstract][Full Text] [Related]
19. Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1. Rowland RJ; Heath R; Maskell D; Thompson RF; Ranson NA; Blaza JN; Endicott JA; Noble MEM; Salamina M Sci Rep; 2023 Jul; 13(1):10718. PubMed ID: 37400515 [TBL] [Abstract][Full Text] [Related]
20. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]